AFP and seminoma: A search for novel biomarkers for seminomas is particularly warranted because the existing clinical markers such as human chorionic gonadotropin (hCG) and/or α-fetoprotein (AFP) are used primarily as reliable biomarkers and proxy for the presence of non-seminomas [5].